AOD-9604 Peptide – User Manual & Dosage Protocol Guide

AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH) designed to mimic the fat-reducing effects of growth hormone without affecting blood sugar or growth pathways.

Research Applications:

• Supporting fat metabolism and weight management research
• Investigating lipolysis and adipose tissue regulation
• Studying metabolic and energy homeostasis effects
• Potential use in anti-obesity and body composition studies

Disclaimer: AOD-9604 is for research and experimental use only. It is not FDA-approved for therapeutic purposes. Consult a qualified healthcare professional before use.

Product FormLyophilized Powder – Freeze-dried AOD-9604 for reconstitution

Injection Solution – Subcutaneous (SC) or intramuscular (IM) solution after reconstitution

Oral Spray / Capsules – Experimental; bioavailability may vary

AOD-9604 functions by:

• Stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat formation)
• Mimicking growth hormone’s fat-reducing effects without influencing blood sugar
• Supporting metabolic regulation and energy balance

Effects are primarily observed in preclinical and experimental studies.

Administration

Subcutaneous (SC) Injection – Typical Dose: 300–500 µg | Frequency: 1–3× per day | Notes: Targeted fat metabolism and body composition studies

Intramuscular (IM) Injection – Typical Dose: 300–500 µg | Frequency: 1–3× per day | Notes: Localized or systemic administration

Oral Spray / Capsules – Typical Dose: 500 µg–1 mg | Frequency: Daily | Notes: Bioavailability may be reduced; effects slower

Cycle Protocol (Investigational)

Initial Phase (2 weeks) – Dose: Lower end of dose range | Notes: Assess tolerance and metabolic response

Therapeutic Phase (4–8 weeks) – Dose: Full dose range | Notes: Maximum fat-reducing and metabolic effect

Rest Period (2–4 weeks) – Dose: None | Notes: Allows system to reset before next cycle

Experimental cycles may be repeated 2–3 times per year, depending on research objectives.

Supplies Needed:

• Sterile bacteriostatic water
• Sterile syringe
• Alcohol swabs

Steps:

1. Clean vial top with alcohol swab.
2. Add desired volume of bacteriostatic water (e.g., 5 mg peptide + 1 mL water → 5 mg/mL solution).
3. Swirl gently to dissolve; do not shake.
4. Store refrigerated (2–8°C).
5. Use within 2–4 weeks; discard if cloudy or discolored.

Subcutaneous Injection (SC)

1. Select a clean injection site (abdomen, thigh, or upper arm).
2. Clean with alcohol swab.
3. Insert needle at 45° angle.
4. Inject slowly; apply gentle pressure afterward.
5. Rotate injection sites daily or every other day.

Intramuscular Injection (IM)

1. Select clean muscle site (deltoid, glute, thigh).
2. Clean with alcohol swab.
3. Insert needle at 90° angle; inject slowly.
4. Apply gentle pressure afterward.

Oral Administration

• Take on an empty stomach for better absorption.
• Daily consistent dosing recommended.

Storage Information

Lyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 12 months

Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 2–4 weeks

Oral Spray / Capsules – Storage: Room temperature, dry place | Shelf Life: 6–12 months

Discard solution if cloudy, discolored, or containing particulates.

• Not recommended for pregnant or breastfeeding women
• Avoid if allergic to peptides
• Mild side effects: injection site irritation, mild nausea, or headache
• Discontinue if severe adverse reactions occur
• Keep out of reach of children

Human clinical data are limited; effects are investigational.

Weekly Dosing ScheduleWeek 1–2 – Dose: 300 µg SC/IM 1× per day | Notes: Initial tolerance phase

Week 3–4 – Dose: 300–500 µg SC/IM 1–2× per day | Notes: Therapeutic phase

Week 5–8 – Dose: 500 µg SC/IM 2–3× per day | Notes: Full effect cycle

Week 9+ – Dose: Rest 2–4 weeks | Notes: Reset before next cycle

• Diagrams of SC and IM injection sites (abdomen, thigh, arm, deltoid, glute)
• Step-by-step reconstitution guide
• Step-by-step oral administration guide
• Safety icons for handling, storage, and injections